Organon Co Stock Performance

OGN Stock  USD 8.21  0.11  1.36%   
Organon has a performance score of 4 on a scale of 0 to 100. The company holds a Beta of 0.57, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Organon's returns are expected to increase less than the market. However, during the bear market, the loss of holding Organon is expected to be smaller as well. Organon right now holds a risk of 2.77%. Please check Organon downside variance, and the relationship between the sortino ratio and accumulation distribution , to decide if Organon will be following its historical price patterns.

Risk-Adjusted Performance

Soft

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Organon Co are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating technical and fundamental indicators, Organon may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more

Actual Historical Performance (%)

One Day Return
1.36
Five Day Return
(2.49)
Year To Date Return
13.4
Ten Year Return
(75.31)
All Time Return
(75.31)
Forward Dividend Yield
0.0099
Payout Ratio
0.1122
Forward Dividend Rate
0.08
Dividend Date
2025-12-11
Ex Dividend Date
2025-11-20
1
Insider Trading
11/14/2025
2
Acquisition by Rachel Stahler of 3579 shares of Organon subject to Rule 16b-3
11/21/2025
 
Organon dividend paid on 11th of December 2025
12/11/2025
3
Organon Beats Stock Market Upswing What Investors Need to Know
12/22/2025
4
Nordea Investment Management AB Has 31.71 Million Position in Organon Co. OGN
01/15/2026
5
Why Organon Is Up 12.2 percent After FDA Extends NEXPLANON Use To Five Years And Adds REMS
01/21/2026
6
Sun Pharma Bid Puts Organon Valuation And Growth Prospects In Focus
01/23/2026
7
Organon Stock Sinks As Market Gains What You Should Know
01/27/2026
8
Mitsubishi UFJ Trust Banking Corp Increases Stock Position in Organon Co. OGN
01/28/2026
9
Organon To Report Fourth Quarter and Full Year 2025 Results and Host Conference Call on February 12, 2026
01/29/2026
Begin Period Cash Flow693 M
Total Cashflows From Investing Activities-513 M

Organon Relative Risk vs. Return Landscape

If you would invest  769.00  in Organon Co on November 9, 2025 and sell it today you would earn a total of  52.00  from holding Organon Co or generate 6.76% return on investment over 90 days. Organon Co is generating 0.1447% of daily returns assuming volatility of 2.7718% on return distribution over 90 days investment horizon. In other words, 24% of stocks are less volatile than Organon, and above 98% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  
Considering the 90-day investment horizon Organon is expected to generate 3.38 times more return on investment than the market. However, the company is 3.38 times more volatile than its market benchmark. It trades about 0.05 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.

Organon Target Price Odds to finish over Current Price

The tendency of Organon Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 8.21 90 days 8.21 
about 26.45
Based on a normal probability distribution, the odds of Organon to move above the current price in 90 days from now is about 26.45 (This Organon Co probability density function shows the probability of Organon Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon Organon has a beta of 0.57. This indicates as returns on the market go up, Organon average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Organon Co will be expected to be much smaller as well. Additionally Organon Co has an alpha of 0.3056, implying that it can generate a 0.31 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Organon Price Density   
       Price  

Predictive Modules for Organon

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Organon. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
5.428.2111.00
Details
Intrinsic
Valuation
LowRealHigh
5.057.8410.63
Details
Naive
Forecast
LowNextHigh
4.206.999.78
Details
7 Analysts
Consensus
LowTargetHigh
8.519.3610.39
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Organon. Your research has to be compared to or analyzed against Organon's peers to derive any actionable benefits. When done correctly, Organon's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Organon.

Organon Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Organon is not an exception. The market had few large corrections towards the Organon's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Organon Co, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Organon within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.31
β
Beta against Dow Jones0.57
σ
Overall volatility
0.81
Ir
Information ratio 0.08

Organon Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Organon for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Organon can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Over 77.0% of the company shares are owned by institutional investors
On 11th of December 2025 Organon paid $ 0.02 per share dividend to its current shareholders
Latest headline from MacroaxisInsider: Insider Trading

Organon Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Organon Stock often depends not only on the future outlook of the current and potential Organon's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Organon's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding259.2 M
Cash And Short Term Investments675 M

Organon Fundamentals Growth

Organon Stock prices reflect investors' perceptions of the future prospects and financial health of Organon, and Organon fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Organon Stock performance.

About Organon Performance

By examining Organon's fundamental ratios, stakeholders can obtain critical insights into Organon's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Organon is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 161.44  123.03 
Return On Tangible Assets 0.14  0.13 
Return On Capital Employed 0.16  0.29 
Return On Assets 0.08  0.07 
Return On Equity 2.11  2.21 

Things to note about Organon performance evaluation

Checking the ongoing alerts about Organon for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Organon help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Over 77.0% of the company shares are owned by institutional investors
On 11th of December 2025 Organon paid $ 0.02 per share dividend to its current shareholders
Latest headline from MacroaxisInsider: Insider Trading
Evaluating Organon's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Organon's stock performance include:
  • Analyzing Organon's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Organon's stock is overvalued or undervalued compared to its peers.
  • Examining Organon's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Organon's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Organon's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Organon's stock. These opinions can provide insight into Organon's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Organon's stock performance is not an exact science, and many factors can impact Organon's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Organon offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Organon's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organon Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organon Co Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organon Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Will Pharmaceuticals sector continue expanding? Could Organon diversify its offerings? Factors like these will boost the valuation of Organon. Anticipated expansion of Organon directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Organon data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
(0.56)
Dividend Share
0.6
Earnings Share
1.91
Revenue Per Share
24.34
Quarterly Revenue Growth
0.013
Investors evaluate Organon using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Organon's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Organon's market price to deviate significantly from intrinsic value.
It's important to distinguish between Organon's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Organon should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Organon's market price signifies the transaction level at which participants voluntarily complete trades.